TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharma Nord Norge AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
52,687
|
33,269
|
35,260 |
| Financial expenses |
66
|
23
|
26 |
| Earnings before taxes |
3,248
|
1,996
|
1,028 |
| Total assets |
19,514
|
13,715
|
18,263 |
| Current assets |
17,935
|
12,034
|
16,471 |
| Current liabilities |
18,293
|
12,518
|
17,013 |
| Equity capital |
1,106
|
1,074
|
1,117 |
| - share capital |
1,000
|
1,000
|
1,000 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.7%
|
7.8%
|
6.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
6.2%
|
6.0%
|
2.9% |
| Return on assets (ROA) |
17.0%
|
14.7%
|
5.8% |
| Current ratio |
98.0%
|
96.1%
|
96.8% |
| Return on equity (ROE) |
293.7%
|
185.8%
|
92.0% |
| Change turnover |
19,418
|
-1,991
|
-3,900 |
| Change turnover % |
58%
|
-6%
|
-10% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.